Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012257183> ?p ?o ?g. }
- W3012257183 endingPage "4049" @default.
- W3012257183 startingPage "4039" @default.
- W3012257183 abstract "To assess the added value of dynamic contrast-enhanced (DCE) in prostate MR in clinical practice.Two hundred sixty-four patients underwent prostate MRI, with T2 and DWI sequences initially interpreted, prior to full multiparametric magnetic resonance imaging (mpMRI) interpretation using a Likert 1-5 scale. A prospective opinion was given on likely benefit of contrast prior to review of the DCE sequence, and retrospectively following full mpMRI review. The final histology result following targeted and/or systematic biopsy of the prostate was used for outcome purposes.Biparametric magnetic resonance imaging (bpMRI) and mpMRI were assigned the same score in 86% of cases; when dichotomising to a negative or positive MRI (Likert score ≥ 3), concordance increased to 92.8%. At Likert score ≥ 3 bpMRI detected 89.9% of all cancers and 93.5% clinically significant prostate cancers (csPCa) and mpMRI 90.7% and 94.6%, respectively. mpMRI had fewer false positives than bpMRI (11.4% vs 18.9%) and a lower Likert 3 rate (8.3% vs 17%), conferring higher specificity (74% vs 67%), but similar sensitivity (95% versus 94%) and ROC-AUC (90% vs 89%). At a positive MRI threshold of Likert ≥ 4, mpMRI had a higher sensitivity than bpMRI (89% versus 80%) and detected more csPCa (89.2% versus 79.6%). DCE was prospectively considered of potential benefit in 27.3%, but readers would only recall 11% of patients for DCE sequences, mainly to assess score 3 peripheral zone lesions. Following full mpMRI review, DCE was considered helpful in 28.4% of cases; in 23/75 (30.6%) of these cases this only became apparent after reviewing the sequence, reasons included increased confidence, presence of safety-net lesions or inflammatory lesions.BpMRI has equivalent cancer detection rates to mpMRI; however, mpMRI had fewer Likert 3 call rates and increased specificity and was subjectively considered of benefit by readers in 28.4% of cases.• bpMRI has similar cancer detection rates to the full mpMRI protocol at a positive MRI threshold of Likert 3. • mpMRI had fewer intermediate category 3 calls (8.3%) than bpMRI (17%) and fewer false positives than bpMRI (11.4% vs 18.9%), conferring higher specificity (74% vs 67%). • Readers considered DCE beneficial in 28.4% of cases, but in a relatively high number (30.6%) this only became apparent after reviewing the sequence." @default.
- W3012257183 created "2020-03-23" @default.
- W3012257183 creator A5023005082 @default.
- W3012257183 creator A5025926870 @default.
- W3012257183 creator A5028460960 @default.
- W3012257183 creator A5029171708 @default.
- W3012257183 creator A5047188789 @default.
- W3012257183 creator A5047219206 @default.
- W3012257183 creator A5057316972 @default.
- W3012257183 creator A5073164534 @default.
- W3012257183 creator A5078740056 @default.
- W3012257183 creator A5091674171 @default.
- W3012257183 date "2020-03-12" @default.
- W3012257183 modified "2023-10-03" @default.
- W3012257183 title "Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice" @default.
- W3012257183 cites W1779241737 @default.
- W3012257183 cites W1827911007 @default.
- W3012257183 cites W2000345009 @default.
- W3012257183 cites W2001957227 @default.
- W3012257183 cites W2042827797 @default.
- W3012257183 cites W2077304070 @default.
- W3012257183 cites W2084530435 @default.
- W3012257183 cites W2118681954 @default.
- W3012257183 cites W2124539070 @default.
- W3012257183 cites W2163300952 @default.
- W3012257183 cites W2199778657 @default.
- W3012257183 cites W2220122664 @default.
- W3012257183 cites W2513664992 @default.
- W3012257183 cites W2531825705 @default.
- W3012257183 cites W2536443940 @default.
- W3012257183 cites W2577453388 @default.
- W3012257183 cites W2587136869 @default.
- W3012257183 cites W2590074218 @default.
- W3012257183 cites W2606151060 @default.
- W3012257183 cites W2736990592 @default.
- W3012257183 cites W2739119600 @default.
- W3012257183 cites W2744748393 @default.
- W3012257183 cites W2749175606 @default.
- W3012257183 cites W2790988768 @default.
- W3012257183 cites W2793905111 @default.
- W3012257183 cites W2805452553 @default.
- W3012257183 cites W2808164498 @default.
- W3012257183 cites W2885894901 @default.
- W3012257183 cites W2900548778 @default.
- W3012257183 cites W2901859788 @default.
- W3012257183 cites W2916348473 @default.
- W3012257183 cites W2922071185 @default.
- W3012257183 cites W2948542363 @default.
- W3012257183 cites W2955550150 @default.
- W3012257183 cites W2980886547 @default.
- W3012257183 doi "https://doi.org/10.1007/s00330-020-06782-0" @default.
- W3012257183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32166495" @default.
- W3012257183 hasPublicationYear "2020" @default.
- W3012257183 type Work @default.
- W3012257183 sameAs 3012257183 @default.
- W3012257183 citedByCount "43" @default.
- W3012257183 countsByYear W30122571832020 @default.
- W3012257183 countsByYear W30122571832021 @default.
- W3012257183 countsByYear W30122571832022 @default.
- W3012257183 countsByYear W30122571832023 @default.
- W3012257183 crossrefType "journal-article" @default.
- W3012257183 hasAuthorship W3012257183A5023005082 @default.
- W3012257183 hasAuthorship W3012257183A5025926870 @default.
- W3012257183 hasAuthorship W3012257183A5028460960 @default.
- W3012257183 hasAuthorship W3012257183A5029171708 @default.
- W3012257183 hasAuthorship W3012257183A5047188789 @default.
- W3012257183 hasAuthorship W3012257183A5047219206 @default.
- W3012257183 hasAuthorship W3012257183A5057316972 @default.
- W3012257183 hasAuthorship W3012257183A5073164534 @default.
- W3012257183 hasAuthorship W3012257183A5078740056 @default.
- W3012257183 hasAuthorship W3012257183A5091674171 @default.
- W3012257183 hasBestOaLocation W30122571832 @default.
- W3012257183 hasConcept C118552586 @default.
- W3012257183 hasConcept C121608353 @default.
- W3012257183 hasConcept C126322002 @default.
- W3012257183 hasConcept C126838900 @default.
- W3012257183 hasConcept C142724271 @default.
- W3012257183 hasConcept C143409427 @default.
- W3012257183 hasConcept C160798450 @default.
- W3012257183 hasConcept C16568411 @default.
- W3012257183 hasConcept C188816634 @default.
- W3012257183 hasConcept C2775934546 @default.
- W3012257183 hasConcept C2776235491 @default.
- W3012257183 hasConcept C2779889316 @default.
- W3012257183 hasConcept C2989005 @default.
- W3012257183 hasConcept C71924100 @default.
- W3012257183 hasConceptScore W3012257183C118552586 @default.
- W3012257183 hasConceptScore W3012257183C121608353 @default.
- W3012257183 hasConceptScore W3012257183C126322002 @default.
- W3012257183 hasConceptScore W3012257183C126838900 @default.
- W3012257183 hasConceptScore W3012257183C142724271 @default.
- W3012257183 hasConceptScore W3012257183C143409427 @default.
- W3012257183 hasConceptScore W3012257183C160798450 @default.
- W3012257183 hasConceptScore W3012257183C16568411 @default.
- W3012257183 hasConceptScore W3012257183C188816634 @default.
- W3012257183 hasConceptScore W3012257183C2775934546 @default.
- W3012257183 hasConceptScore W3012257183C2776235491 @default.
- W3012257183 hasConceptScore W3012257183C2779889316 @default.